Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide-Reference-Cited by-同舟云学术

Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide

Published:2012 Issue:17 Volume:51 Page:2375-2378
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yamamoto Sunao¹,Okada Yosuke¹,Mori Hiroko¹,Fukumoto Seiji²,Tanaka Yoshiya¹

Affiliation:

1. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan

2. Division of Nephrology and Endocrinology, Department of Medicine, University of Tokyo, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/17/51_51.7450/_pdf

Reference9 articles.

1. 1. Okada M, Imamura K, Iida M, Fuchigami T, Omae T. Hypophosphatemia induced by intravenous administration of Saccharated iron oxide. Klin Wochenschr 61: 99-102, 1983.

2. Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy.

3. 4. Bringhurst FR, Demay MB, Krane SM, Kronenberg HM. Bone and mineral metabolism in health and disease. In: Harrison's Principles of Internal Medicine. 17th ed. Fauci AS, Braunwald E, Kasper DL, et al, Eds. McGraw-Hill, New York, 2008: 2365-2377.

4. FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study

5. 7. Sanai T, Oochi N, Okada M, Imamura K, Okuda S, Iida M. Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats. J Lab Clin Med 146: 25-29, 2005.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency;Journal of the American College of Cardiology;2024-06

2. Ostéomalacie hypophosphatémique induite par l’administration de fer injectable;Revue du Rhumatisme;2023-10

3. Hypophosphatemic osteomalacia induced by intravenous iron therapy: a case report;Joint Bone Spine;2023-09

4. Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study;International Journal of Hematology;2022-07-06

5. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports;Journal of Bone and Mineral Research;2022-05-07